After myocardial infarction (MI), patients with type 2 diabetes have an increased rate of
adverse outcomes, compared to patients without. Diabetes confers a 1.5–2-fold increase in …

Aims Accurate prediction of clinical outcomes following percutaneous coronary intervention
(PCI) is essential for mitigating risk and peri-procedural planning. Traditional risk models …

Importance Individuals with type 2 diabetes (T2D) have high rates of mortality following
myocardial infarction (MI). Hospitalization is an opportunity to initiate or continue evidence …

Background Persistent efforts are required to further reduce the in-hospital mortality of
patients suffering from acute myocardial infarction (AMI), even in the face of a global trend of …

Background Type 2 diabetes has traditionally been a risk factor for worse prognosis after
myocardial infarction (MI), but major advances have been made in its treatment, and the use …

Abstract Objects This study aimed to investigate the impact of lipoprotein (a)[Lp (a)] levels on
the prognosis of Chinese patients with ST-segment elevation myocardial infarction (STEMI) …

Background: Diabetes mellitus (DM) increases the risk of mortality in patients with acute
myocardial infarction (AMI). The impact of the diabetes duration on the long-term outcome of …

Background The aim of this study was to investigate temporal trends in survival and
subsequent cardiovascular events in a nationwide myocardial infarction population with and …

Background Cardiovascular disease is the major cause of morbidity and mortality,
particularly in type 2 diabetes mellitus (T2DM). Novel markers of insulin resistance and …

Acute myocardial infarction (AMI) continues to be a predominant cause of global morbidity
and mortality, with in-hospital mortality (IHM) serving as a pivotal metric for patient outcomes …